Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant

Clinical trial NCT00691015 · COMPLETED

Trial details

NCT number: NCT00691015
Sponsor: Barbara Ann Karmanos Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Myeloproliferative Disorders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms

Start date: 2008-05-01
Primary completion: 2014-04-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.